Details for Patent: 9,950,125
✉ Email this page to a colleague
Which drugs does patent 9,950,125 protect, and when does it expire?
Patent 9,950,125 protects XYOSTED (AUTOINJECTOR) and is included in one NDA.
This patent has twenty-nine patent family members in ten countries.
Summary for Patent: 9,950,125
Title: | Needle assisted jet injection administration of testosterone compositions |
Abstract: | The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device. |
Inventor(s): | Wotton; Paul K. (Newtown, PA), Dave; Kaushik J. (Edison, NJ), Hayes; John W. (Chaska, MN), Sadowski; Peter L. (Woodbury, MN), Jooste; Hermanus L. (Wayne, PA), Jaffe; Jonathan (Annandale, NJ) |
Assignee: | ANTARES PHARMA, INC. (Ewing, NJ) |
Application Number: | 13/857,859 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 9,950,125
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-001 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY | ⤷ Try a Trial | |||
Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY | ⤷ Try a Trial | |||
Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,950,125
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013203784 | ⤷ Try a Trial | |||
Canada | 2868500 | ⤷ Try a Trial | |||
Canada | 2900672 | ⤷ Try a Trial | |||
China | 104487114 | ⤷ Try a Trial | |||
Denmark | 2953667 | ⤷ Try a Trial | |||
European Patent Office | 2731645 | ⤷ Try a Trial | |||
European Patent Office | 2833944 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |